Neogenomics (NEO) Tops Q2 EPS by 1c; Guides Q3, FY13

July 31, 2013 7:52 AM

Neogenomics (NASDAQ: NEO) reported Q2 EPS of $0.01, $0.01 better than the analyst estimate of $0.00. Revenue for the quarter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found